Perivascular spaces as a marker of disease severity and neurodegeneration in patients with behavioral variant frontotemporal dementia.

Moses, Jasmine; Sinclair, Benjamin; Schwartz, Daniel L; Silbert, Lisa C; O'Brien, Terence J; Law, Meng; Vivash, Lucy

Moses, Jasmine; Sinclair, Benjamin; Schwartz, Daniel L; Silbert, Lisa C; O'Brien, Terence J; Law, Meng; Vivash, Lucy.

Afiliación

Moses J; Department of Neuroscience, Central Clinical School, Monash University, Melbourne, VIC, Australia.
Sinclair B; Department of Neuroscience, Central Clinical School, Monash University, Melbourne, VIC, Australia.
Schwartz DL; Department of Neurology, Alfred Hospital, Melbourne, VIC, Australia.
Silbert LC; Department of Medicine, Royal Melbourne Hospital, University of Melbourne, Melbourne, VIC, Australia.
O'Brien TJ; NIA-Layton Oregon Aging and Alzheimer's Disease Research Center, Oregon Health & Science University, Portland, OR, United States.
Law M; Advanced Imaging Research Center, Oregon Health and Science University, Portland, OR, United States.
Vivash L; NIA-Layton Oregon Aging and Alzheimer's Disease Research Center, Oregon Health & Science University, Portland, OR, United States.

Front Neurosci ; 16: 1003522, 2022.

Article en En | MEDLINE | ID: mdl-36340772

Palabras clave

Behavioural Variant Frontotemporal Dementia; anti-tau therapy; clinical trial; frontotemporal lobar degeneration; perivascular spaces; sodium selenate; tau

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Front Neurosci Año: 2022 Tipo del documento: Article País de afiliación: Australia Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google